PGEN
Precigen Inc
NASDAQ: PGEN · HEALTHCARE · BIOTECHNOLOGY
$4.16
+0.97% today
Updated 2026-04-30
Market cap
$1.46B
P/E ratio
—
P/S ratio
150.58x
EPS (TTM)
$-1.37
Dividend yield
—
52W range
$1 – $5
Volume
4.6M
Precigen Inc (PGEN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-81.76M | $-61.53M | $-53.68M | $-19.86M | $35.67M | $-55.98M | $-104.14M | $-124.24M | $-77.02M | $-77.02M | $-55.77M | $-65.05M | $-66.93M | $-68.17M | $-87.83M |
| Capital expenditures | $13.00M | $7.49M | $1.53M | $6.37M | $12.75M | $31.63M | $46.67M | $41.59M | $7.53M | $7.53M | $7.25M | $4.92M | $1.54M | $8.58M | $2.00M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $992000.00 | $1.55M | $3.04M | $22.34M | $100.42M | $52.98M | $52.69M | $46.99M | $18.37M | $18.37M | $13.90M | $10.21M | $9.89M | $9.47M | $10.87M |
| Free cash flow | $-94.76M | $-69.02M | $-55.21M | $-26.23M | $22.92M | $-87.60M | $-150.81M | $-165.83M | $-84.55M | $-84.55M | $-63.02M | $-69.97M | $-68.47M | $-76.76M | $-89.83M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $150.91M | $6.98M | — | $41.98M | $7.73M | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-22.04M | $108.32M | $-73.17M | $5.50M | $34.34M | $-40.94M | $-16.54M | $-9.12M | $6.08M | — | — | — |